DELFI Diagnostics
DELFI Diagnostics is a biotechnology company based in Maryland, focused on early cancer detection through advanced genomic analysis and machine learning. The company specializes in next-generation liquid biopsy technologies that identify cancer-associated DNA fragmentation patterns in blood samples. With a team of 51-200 employees, DELFI aims to make cancer screening accessible and effective, particularly for high-risk populations. The company's core technology includes a fragmentomics platform that analyzes millions of DNA fragments using whole genome sequencing and machine learning. This allows for high-sensitivity detection of multiple cancer types through blood-based tests, which are designed to be integrated into routine clinical practice. DELFI's early detection tests target asymptomatic cancer, enhancing screening options for individuals who may face barriers to traditional methods. DELFI has established strategic partnerships, including collaborations with the Merck Global Health Innovation Fund and Incendia Therapeutics, to support its growth and commercialization efforts. The company is committed to advancing cancer detection methodologies and has been recognized for its innovative approach in recent industry presentations.
Work at DELFI Diagnostics in HR or recruiting? Claim this page
Headcount trend
DELFI Diagnostics went from 142 employees in Oct 2024 to 114 in Sep 2026. Apr to Sep 2026: 5 people joined, 4 left.
Funding rounds
| Date | Round | Money raised | No. | Investors |
|---|---|---|---|---|
| Jun 2024 | Funding | – | 1 | |
| Jul 2022 | Series B | $225M | 18 | |
| Jan 2021 | Series A | $100M | 9 | |
| Aug 2019 | Venture | $5.5M | 5 | |
| Jun 2018 | Funding | $15.3K | – | – |
Org structure
Headcount by department
H-1B sponsorship
The department split adds up all the years listed above. FY2026 alone: 2 filings.
Peer reviews
Worked with someone at DELFI Diagnostics?
Anonymous peer reviews on OffTheRecord
Similar companies
Hiring now
DELFI Diagnostics FAQ
How many employees does DELFI Diagnostics have?
DELFI Diagnostics has about 114 employees, up 2.7% over the 3 months to Sep 2026.
Does DELFI Diagnostics sponsor H1B visas?
Yes. DELFI Diagnostics filed 2 H1B (LCA) applications in FY2026, according to the latest U.S. Department of Labor disclosures. Most of them were for Engineering roles.
What is DELFI Diagnostics's revenue per employee?
DELFI Diagnostics makes about $67K in revenue per employee, based on $7.6M annual revenue and 114 employees.
How much funding has DELFI Diagnostics raised?
DELFI Diagnostics has raised $330.52M in total funding.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.